Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey

Gastroenterology. 2020 Feb;158(3):786-788.e1. doi: 10.1053/j.gastro.2019.10.036. Epub 2019 Nov 9.

Abstract

Many treatments for irritable bowel syndrome are available to those with the disease. Satisfaction with these treatments is low, and a need exists for further effective treatments for the condition.

Keywords: Constipation; Diarrhea; Irritable Bowel Syndrome; Patient Satisfaction; Physician Satisfaction; Treatment Utilization.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Attitude of Health Personnel*
  • Constipation / drug therapy*
  • Constipation / etiology
  • Diarrhea / drug therapy*
  • Diarrhea / etiology
  • Diet
  • Dietary Fiber / administration & dosage
  • Dietary Supplements
  • Dioctyl Sulfosuccinic Acid / therapeutic use
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Health Care Surveys
  • Humans
  • Irritable Bowel Syndrome / complications
  • Irritable Bowel Syndrome / therapy*
  • Laxatives / therapeutic use
  • Lubiprostone / therapeutic use
  • Male
  • Middle Aged
  • Parasympatholytics / therapeutic use
  • Patient Satisfaction*
  • Probiotics / therapeutic use
  • Rifaximin / therapeutic use

Substances

  • Dietary Fiber
  • Gastrointestinal Agents
  • Laxatives
  • Parasympatholytics
  • Dioctyl Sulfosuccinic Acid
  • Lubiprostone
  • Rifaximin